GO 102
Alternative Names: GO-102Latest Information Update: 07 Jul 2021
At a glance
- Originator Generoath
- Class Gene therapies
- Mechanism of Action Gene transference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Amyotrophic lateral sclerosis
Most Recent Events
- 06 Jul 2021 Generoath has patents pending for pharmaceutical composition for prevention or treatment of neurological disease and use thereof, before July 2021 (Generoath website, July 2021).
- 06 Jul 2021 Generoath plans to file an IND application in South Korea for Amyotrophic lateral sclerosis (Generoath pipeline, July 2021)
- 06 Jul 2021 Generoath plans a clinical trial for Amyotrophic lateral sclerosis in South Korea (Generoath website, July 2021)